Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Emergency services have declared a "major incident" in Leicester following reports of an explosion.
Parts of the UK will feel colder than the Arctic Circle in the coming week as bitter winds make it feel -15C in some places.